CAPSTONE NATIONAL PARTNERS

Lobbying for ATTERX BIOTHERAPEUTICS · Biotherapeutical development

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Wisconsin · House · Senate · $15,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

FY27 Appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem